Literature DB >> 18812039

Change in the risk of tuberculous infection over an 8-year period among schoolchildren in Bangalore City.

V K Chadha1, R Jithendra, P Kumar, R Kirankumar, A N Shashidharan, P Suganthi, J Gupta, P S Jaganath.   

Abstract

SETTING: Bangalore City, South India.
OBJECTIVE: To estimate the trends in transmission of tuberculous infection.
METHODS: Two tuberculin surveys were carried out among children attending grades 1 and 2 of 60 selected schools at an interval of 8.3 years, corresponding to the period of DOTS expansion. Tuberculin testing was carried out using 1 tuberculin unit (TU) of purified protein derivative (PPD) RT 23 with Tween 80, and the maximum transverse diameter of induration was recorded about 72 h later. As the reactions due to infection with tubercle bacilli could not be clearly delineated from cross-reactions on the frequency distributions of tuberculin reaction sizes at either survey, the prevalence of tuberculin reactions > or = 10 mm, > or = 12 mm and > or = 14 mm in size were compared between the two surveys. The annual risk of tuberculous infection (ARTI) was computed from the estimated prevalence of reactions > or = 14 mm in size.
RESULTS: Estimates of prevalence of reactions at all chosen cut-off points were lower at Survey II compared to Survey I. These differences were statistically significant. An average per annum decline in ARTI of about 4% was observed between the two surveys.
CONCLUSION: Tuberculosis control measures should be further intensified to enhance the rate of decline in transmission of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812039

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  2 in total

1.  India's Progress Toward Achieving the Millennium Development Goals.

Authors:  Anita Nath
Journal:  Indian J Community Med       Date:  2011-04

2.  Trend in annual risk of tuberculous infection in north India.

Authors:  Kamal Chopra; Vineet K Chadha; Jitendra Ramachandra; Nishi Aggarwal
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.